Rob Sahr on the Administration’s Aggressive Approach to Bayh-Dole Compliance
On December 7, 2023, the Biden administration announced a blueprint for a framework that may be a tough pill to swallow for the pharmaceutical industry. This framework suggests that drug prices should be a crucial factor in...more